| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| GTO ID | GTC2933 |
| Trial ID | NCT05239689 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD38 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD38 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | CD38-001 |
| Cohort 1 | |||||||||
|
|||||||||